보관된 글 — US — techcrunch
Genetics testing startup Nucleus Genomics criticized for its embryo product:‘Makes me so nauseous’
Nucleus Genomics faces backlash over its new product, Nucleus Embryo, which allows parents to choose specific traits for their children from IVF embryos, including intelligence. Critics argue this promotes 'designer babies' and raises ethical concerns, as the product utilizes controversial polygenic scores, which are not widely accepted in medical practice for individual assessment.
핵심 정리
- Nucleus Genomics, founded in 2021 by Kian Sadeghi, initially aimed to assess disease risks.
- The company announced the Nucleus Embryo product, claiming it can help parents select embryos based on traits like sex, height, and intelligence.
- Critics, including scientists, express concern over the ethical implications of 'designer babies' and the use of polygenic scores, which only predict probabilities, not certainties.
- Polygenic risk scores are still under research, leading to disagreements over their reliability in clinical settings.
- Nucleus previously faced controversy with its product, Nucleus IQ, which claimed to measure genetic influence on intelligence.
- The company partners with Genomic Prediction for IVF testing, but isn't conducting such tests directly.
왜 중요한가
- The trend of genetic engineering and enhancements has gained momentum in recent years, paralleling advancements in genetic testing technologies.
- The ethical debates around genetic selection echo past discussions around eugenics and the implications of 'designer babies' in society.
- As of 2025, public awareness and concerns over genetic privacy and ethical boundaries in biotechnology are heightened, following decades of rapid genetic advancements.
Nucleus Genomics' controversial Nucleus Embryo product stirs ethical debates on genetic selection, reflecting broader societal concerns about the future of genetic testing and child design, underscoring the need for established guidelines and ethical practices.